Modified alginates for anti-fibrotic materials and applications
US10898443B2 · kind B2 · utility
1Cited by
19References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 22, 2018 |
| Grant date | Jan 26, 2021 |
| Priority date | — |
| Expiry date | Dec 5, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N5/0677
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for coating of any material where reduced fibrosis is desired, such as encapsulated cells for transplantation and medical devices implanted or used in the body.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.